International Clinical Trial: Study on the Effects of Different Doses of Dexmedetomidine Hydrochloride on the Expression Levels of Inflammatory Factors and Prognosis in Patients with Acute Gastrointestinal Perforation Complicated with Sepsis after Surgery

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120120) titled 'Study on the Effects of Different Doses of Dexmedetomidine Hydrochloride on the Expression Levels of Inflammatory Factors and Prognosis in Patients with Acute Gastrointestinal Perforation Complicated with Sepsis after Surgery' on March 10.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Xuzhou Medical University Affiliated Hospital

Condition: Gastrointestinal perforation (sepsis)

Intervention: High-dose group (0.75 ug/kg/h):Dexmedetomidine hydrochloride is infused at a rate of 0.75 micrograms per kilogram per hour. The medium-dose group:Dexmedetomidine hydrochloride is infused at ...